In a significant development in healthcare technology, patients at risk of genetic kidney disease could soon benefit from a groundbreaking approach to AI diagnosis. Artificial intelligence (AI) is being harnessed to analyze MRI scans, providing assessments of organ health at an unprecedented speed. This advancement, capable of spotting enlarged kidneys six times faster than traditional
